Course Description
The Cardiovascular and Hematologic Systems (CVH) Block is designed to provide instruction in the basic and clinical sciences required for examination and treatment of disorders of the Hematology and Cardiovascular Systems. This Block will provide a comprehensive and in-depth study of these sciences, including for the cardiovascular system: cardiovascular development and histology, cardiovascular physiology, including electrophysiology and hemodynamics, cardiac pathology, pertinent cardiac microbiology and cardiovascular pharmacology. For the hematologic system, the block will provide a comprehensive and in-depth study of the blood and lymphoreticular system, including pertinent biochemistry, histology and histopathology, immunology, oncology, microbiology and pharmacology. In addition to the above topics, radiological imaging, transfusion medicine, stem cell transplantation, bioinformatics, public health and prevention, health equity and race-conscious medicine, psychosocial aspects of illness, and medical ethics, will be presented.
Learning Objectives
Educational Program Objectives are a subset of more broadly defined physician competencies, which represent general domains of performance for which the profession and the public hold physicians accountable.
Upon completing the Cardiovascular-Hematology Block, students should be able to:
- Develop fundamental knowledge of the normal hematological and cardiovascular systems, including function, anatomy, histology, embryology, physiology, biochemistry and hemodynamics.
- Understand hematological and cardiovascular diseases and outline by pathology, pathophysiology, and clinical presentations, including bleeding and thrombotic disorders, congenital heart disease, valvular disease, myocardial disease, inflammatory processes, and infectious diseases.
- Explain how microbial characteristics and the host immune response affect the etiology of infectious disease within the hematologic and cardiovascular systems, interpret common diagnostic tests for infection, identify preventive measures, and predict response to antimicrobial therapy.
- Discover the pathobiological basis, genetic changes and principles underlying the detection, diagnosis, staging, grading, and prevention of hematologic malignancies, including but not limited to lymphoma, leukemia, and myeloma.
- Critically interpret relevant clinical studies and imaging, including laboratory studies, the electrocardiogram and chest radiography, and identify the appropriate use of testing and imaging in the hematological and cardiovascular domains.
- Discuss treatments for cardiovascular disorders, hematologic disorders and hematologic malignancies, including transfusion therapies, hematopoietic stem cell transplant, radiation, molecular target therapy, immunotherapy, non-pharmacological therapies, and preventative care.
- Compare and contrast pharmaceutical drugs of the hematological and cardiovascular systems, including but not limited to anticoagulants, chemotherapy, antiarrhythmics, antihypertensives, sympathomimetics, inotropes, antianginals, and drugs with cardiovascular adverse effects, and distinguish by mechanisms of action, clinical effects, and adverse reactions.
- Recognize the psychosocial impact of acute and chronic disease on patients and families and the various approaches to effectively communicating with and supporting patients and their families.
- Demonstrate awareness of and assess information in educational resources regarding issues of diversity, health equity, behavioral and social sciences, public health and disease prevention, clinical ethics, delivery of health care, bioinformatics and biotechnology as they apply to hematology and cardiovascular disease.